Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Amwill Health Care Ltd. appears to be underperforming relative to its peers in terms of growth and profitability metrics. However, it presents a low valuation with a PE of 10.61, making it a potential value pick but with significant risks due to its lack of growth and profitability compared to peers. Companies like Sun Pharmaceutical Industries and Dr. Reddy's Laboratories showcase strong profitability and growth, positioning them as sector leaders.
Highest revenue growth (YoY 8.42%) and EPS (45.55), indicating strong performance.
Solid profitability metrics with high ROE (21.76%) and low PE (15.50), making it attractive.
Strong growth trajectory with 13.28% revenue growth and attractive PEG of 0.35.